Pain and Emotional Well-Being Outcomes in Southwest Oncology Group–Directed Intergroup Trial S0205: A Phase III Study Comparing Gemcitabine Plus Cetuximab Versus Gemcitabine As First-Line Therapy in Patients With Advanced Pancreas Cancer

PURPOSE: S0205 was a randomized clinical trial that compared the therapeutic impact of gemcitabine versus gemcitabine plus cetuximab. Study results for patient-reported health-related quality of life (HRQL) outcomes are reported. PATIENTS AND METHODS: Patients completed the Brief Pain Inventory and...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Moinpour, Carol M., Vaught, Nancy L., Goldman, Bryan, Redman, Mary W., Philip, Philip A., Millwood, Barbara, Lippman, Scott M., Seay, Thomas E., Flynn, Patrick J., O'Reilly, Eileen M., Rowland, Kendrith M., Wong, Ralph P., Benedetti, Jacqueline, Blanke, Charles D.
Format: Artigo
Sprache:Inglês
Veröffentlicht: American Society of Clinical Oncology 2010
Schlagworte:
Original Reports
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2917316/
https://ncbi.nlm.nih.gov/pubmed/20606094
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.25.8285
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge